{"name":"IRCCS Ospedale San Raffaele","slug":"irccs-ospedale-san-raffaele","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi9wFBVV95cUxOQkMwT1VXTkEtOEgwQWVUMW42WkxjT291S0dXdDVCQ21PcG5sYm9STUhmODdSRi1YckJ0QzdzSWM3Q3NrUVFZMEhnM0RFNUpuOHFwT3NQV2RJMzA0S1dDcnpqOU4zR2JtMzRHa0RxRDlaQ0xfQVY3NldTUl9JeXBZbFdEYUJHRFRjcWZSMktQemplaHNGemt6dTk4ZDRaQkZRVzlSdDgxRmM0RmltY2JPQk80MEItSnV5VWtNUi1HM0x2czVNUDBwREw2emtqOVlQVjZvejA1Qkk3UTVPODljX2NCTmlpZDNqeFlyQnZkTlA3bG1RajZR?oc=5","date":"2026-02-12","type":"pipeline","source":"businesswire.com","summary":"Thetis Pharmaceuticals Expands Scientific Advisory Board with Leading Experts in Inflammatory Bowel Disease - businesswire.com","headline":"Thetis Pharmaceuticals Expands Scientific Advisory Board with Leading Experts in Inflammatory Bowel Disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxOVGpaU0NMeFA5ci1tMFZLYWFrT1JwdHp5VmgyQld5SDl5UExyZXBROFlnTVliM3hBcmhNT1NUdC16XzFyUTBsdVNYbURJWUFSdmh5SlgxUV9OYzl3eWFxVDJIOV9BclA3dC1ZZkdDajBSQlY1bllXNTFUTWdSRm1TeHRTN0dBZUpwbE9xU0VFYkNsVHF2cV90ckExbm5kN1E0dTMzZnUxRjVLUTZUNTlRdXdNMmxoOVNzaUxHT3o1OC0?oc=5","date":"2026-01-21","type":"pipeline","source":"Il Sole 24 ORE","summary":"A drug originally developed for sleep disorders re-emerges as a candidate against multiple sclerosis - Il Sole 24 ORE","headline":"A drug originally developed for sleep disorders re-emerges as a candidate against multiple sclerosis - Il Sole 24 ORE","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxNeEJlNms4UnJKZHk2cDhsaTNlMWN0R2VOMXZQSjM5UWFYVzl6aDJuT3NpQlYzR0RSNWlVamNyaGhUSVBVR1d4bEdpdzh0cTRzVUpoVnduWE5TNlJDdkJPa0R4RlRlQU4xS0RTWVN6WlM1Y3BZUi1BWFRJZnFuV1dUX3ZVajhLb043ZTdwMVdWWl9BOVcwUjZtMnhKRUJrMHU1NDJvMg?oc=5","date":"2026-01-16","type":"pipeline","source":"The Pharma Letter","summary":"EC authorization for Waskyra for Wiskott-Aldrich syndrome - The Pharma Letter","headline":"EC authorization for Waskyra for Wiskott-Aldrich syndrome","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwJBVV95cUxPTEJjaS1hdDZBdHl6ZzNoTFZpRl96VlNraWJHcUJrZjFEbnUyTzN1bWFKY091TjVVQXlZM0JMcmtaRXhvdXVsSWxQQUllbG5fckdWN2NCX0Q3S0liOVZyb242M3c5eHpzQUQ3cW9KWDBUQlhmbjRIQ25ueWVZS0xQbzZ2cEhCc0NuVHczOUFpOW4wakthUWhCcjRMX3dyektMV1IwQWFxVTVpNUkyUnFDdjd3X01icGN0WkY3c19FU2RYc09ncjlrMXRPNUZXZ1d1bkRwV0ZsbjdaUmdpZDBycEpNZmgxOURjaVMyRDN2SkZaZDRoRExLcnRfZ1c2dnA5YkJtVDNHcnJYUC1paEk3WkVjbTczNU1DcDhhdmNFTkN2ZlNFVHZmSU52VEFFMkEtWWtPLWEwaXdFWDRmZmFDeEVlem9BczA?oc=5","date":"2025-12-10","type":"regulatory","source":"Ricerca Malattie Genetiche Rare","summary":"Announced FDA approval of a Gene Therapy for Wiskott-Aldrich Syndrome - Ricerca Malattie Genetiche Rare","headline":"Announced FDA approval of a Gene Therapy for Wiskott-Aldrich Syndrome","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxQTjRraTRWZmFyVmVnRlJxQkt1VGd0aERXUWpMcTlXUTNPdG8zWGJHSE1Oa2ducmRXODloZ1VTdGsxd2FHbHNwUXFLV2xlS1F5UjlxRl9wcEgweVJ2T3N5NUFxSms1Wk1HOWhkWHNHZW1NSEVsRndnMzdtMlRfdm9pMmhjNkw5cDNVb2ZNSExzdw?oc=5","date":"2025-12-10","type":"regulatory","source":"Pharmaceutical Executive","summary":"FDA Approves Waskyra For Treatment of Wiskott-Aldrich Syndrome - Pharmaceutical Executive","headline":"FDA Approves Waskyra For Treatment of Wiskott-Aldrich Syndrome","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxPcF94bWtNblJfSlo4UlZOYXV0WnQyRkFyYWF6clVvUXFBd0ptRjViRjlEemFBN19oUFNZUFhhM3lldThzSW9ob00tRUU5bzhJeFA3TVBpcjlXel9ITjU3bnZUbWowVG5CQ0ZwUkQwUVcwWkEwLWt6U2YtaTk2azVCRXN1a2ViUGJZWXA4Z0xubjNXNW92VXVpRF9wcW1acTdjdzcxallzQXluNVdrd2N2VnR5ZHV0MXpLZHlpRVp2Tkg?oc=5","date":"2025-11-26","type":"pipeline","source":"PsyPost","summary":"Researchers identify a potential neural pathway from childhood trauma to feelings of powerlessness - PsyPost","headline":"Researchers identify a potential neural pathway from childhood trauma to feelings of powerlessness","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTE9ZWnF1Q0pBRlhUbjdhdnFFRDFFbHlWeTRTVzhPYzR1cV91S01jdE1Ka21mQnBkZXVqcDBRbHZFdFliYUg1c2M4bUxaN1A5dEZyV1pLc0lMaDA1TjJuODE1RE53?oc=5","date":"2025-08-07","type":"pipeline","source":"ACS Publications","summary":"Polydopamine Nanoparticles as a Potential Non-Pharmaceutical Antioxidant Tool against Mitochondrial Disorders - ACS Publications","headline":"Polydopamine Nanoparticles as a Potential Non-Pharmaceutical Antioxidant Tool against Mitochondrial Disorders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBGd3E1bUJUcEhRZ1BQQ2ozTzluVm9KbHo3OEYzQmpZUC1iVGdhRU9zUkN2azVvYk94QTdVbUZVOHNsVGJrRk53dFVZMnVzNmZrZV8tOTZETklzanZ3Q21r?oc=5","date":"2025-04-22","type":"pipeline","source":"nature.com","summary":"Shaping the future of inflammatory bowel disease: a global research agenda for better management and public health response - nature.com","headline":"Shaping the future of inflammatory bowel disease: a global research agenda for better management and public health respo","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxOalJMd3BMMlo3Yk84azhUV0NKZDF2UlBud2JnVDNSNHk2LWw5TU0xQnpROUJQUnlIQlg3NTBUZHVpRmVKNGdGdzNPY08yRnJTeHh5bHdHZ0dmYWhmcEtLOVNQdEhwZ2QzV2hsRkZZeC1RclFKXzQwZkxWS1B6RnctVjJQX25leExPTl9UNDJ3MnBMbmdyUnhCUmVyamJFTjRHTVJpQQ?oc=5","date":"2025-03-03","type":"regulatory","source":"PharmTech.com","summary":"EMA Gives Positive Opinion to Lilly Treatment for Chronic Lymphocytic Leukemia - PharmTech.com","headline":"EMA Gives Positive Opinion to Lilly Treatment for Chronic Lymphocytic Leukemia","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-01-15","type":"pipeline","source":"PR Newswire UK","summary":"San Raffaele Hospital (Milan, Italy): new, promising results from the first patients implanted with the spinal neurostimulator. A new, high-frequency spinal stimulation protocol gives hope for motor r","headline":"San Raffaele Hospital (Milan, Italy): new, promising results from the first patients implanted with the spinal neurostim","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxQX0V0cW5ISkg1ZVVxWFBzQ0xJMzVPYnhRTUV0X2VQNHhyQlJiMEUxRjFxNEVIVE9IWTNkM0ZQU0FJUVoweVE3eFlRaHZjYUtack93YzlGWEdEMVNqckY1NmlaRlJBcUZFX3Z3dmk5YzRjRV9IQV9JS3ducWw1ekcxY0FUMWdxamtLMG9rbHNPbDNhcl9JUk9IU1A2QUdTb0FXWXVSRGxxVW9Jd3Q2SUtDbWdKS0tQdw?oc=5","date":"2023-07-20","type":"pipeline","source":"ASCO Daily News","summary":"Triplet Therapy for mHSPC: How Can We Optimize Patient Outcomes While Minimizing Treatment Toxicity? - ASCO Daily News","headline":"Triplet Therapy for mHSPC: How Can We Optimize Patient Outcomes While Minimizing Treatment Toxicity?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxNRkpzSEtsWmRWV0xqdExFWlJpTFl3N0xIU2xLTDV0N2JpakZZdkREMGlTVFZFa0NxaG5oZ0NCXzR0WlZuNDNJYXRUa1kzYjJFTWVFUjBfZy1KN1Ftcmo3anhvWlpXb0l1UjhubFZJWUdvbER2YzRkbkV1enNERFY4ZWVTelVBRFZCb09BXzdqYUw5R2tDU2VBN2lkQnFoWklHM1dEcXFzbFNfNFVyQTRwcURaWmtROFRNY1A5dg?oc=5","date":"2019-04-29","type":"trial","source":"Intellia Therapeutics - investor relations","summary":"Intellia Therapeutics Presents New In Vivo and Engineered Cell Therapy Data at the 22nd Annual Meeting of the American Society of Gene and Cell Therapy - Intellia Therapeutics - investor relations","headline":"Intellia Therapeutics Presents New In Vivo and Engineered Cell Therapy Data at the 22nd Annual Meeting of the American S","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}